Literature DB >> 11096223

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.

A Wallin1, M Sjögren, A Edman, K Blennow, B Regland.   

Abstract

The aim was to study the frequently found white-matter changes on computerized tomography (CT) in patients with dementia and to relate these changes to clinical regional brain symptomatology, vascular factors, albumin ratio [indicator of blood-brain barrier (BBB) function] and other CT changes. The study included 85 patients, average age 71 +/- 8, with Alzheimer's disease (n = 56) and vascular dementia (n = 29), who underwent CT (Siemens Somatome DR 1) of the brain. They were inpatients in a psychiatric department specialized in dementia investigations. The degree of CT white-matter changes (absence, mild-moderate, severe) was the basis for the division of the patients into three groups. As the patients without white-matter changes were significantly younger than those with such changes, all statistical analyses were controlled for age. Subcortical symptomatology was significantly more frequent in the group with severe white-matter changes, whereas the reverse was true for parietal symptomatology. Diabetes mellitus, hypertension, ischemic cardiac disease and lacunas were significantly more common in patients with white-matter changes, whereas the frequency of transient ischemic attack/stroke episodes did not differ significantly between the groups. The albumin ratio was significantly higher in the groups with white-matter changes and highest in the group with severe white-matter changes. The findings indicate that white-matter changes in demented patients are at least partially an age- and stroke-independent disease manifestation of the vascular system and is associated with a specific symptom pattern. BBB dysfunction may be the link between the vasculature and the tissue damage. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096223     DOI: 10.1159/000008242

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  32 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  Blood-brain barrier and Alzheimer's.

Authors:  Jim Sondecker; Michael Smith; Dave Robinson
Journal:  Psychiatry (Edgmont)       Date:  2005-06

3.  Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Authors:  Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

4.  Global Performance of Executive Function Is Predictor of Risk of Frailty and Disability in Older Adults.

Authors:  C Rosado-Artalejo; J A Carnicero; J Losa-Reyna; C Castillo; B Cobos-Antoranz; A Alfaro-Acha; L Rodríguez-Mañas; F J García-García
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  In vivo vascular hallmarks of diffuse leukoaraiosis.

Authors:  Jinsoo Uh; Uma Yezhuvath; Yamei Cheng; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

Review 6.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

7.  Vascular dementia.

Authors:  Ae Young Lee
Journal:  Chonnam Med J       Date:  2011-08-31

8.  White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke.

Authors:  Jieli Chen; Xu Cui; Alex Zacharek; Yisheng Cui; Cynthia Roberts; Michael Chopp
Journal:  Stroke       Date:  2010-12-30       Impact factor: 7.914

9.  Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.

Authors:  Andrew M Demchuk; Firosh Khan; Michael D Hill; Philip A Barber; Brian Silver; Suresh Patel; Steven R Levine
Journal:  Cerebrovasc Dis       Date:  2008-06-17       Impact factor: 2.762

10.  Blood-Brain Barrier Permeability in Aging and Alzheimer's Disease.

Authors:  G A Rosenberg
Journal:  J Prev Alzheimers Dis       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.